Amgen’s Lumykras gains MHRA approval under Project Orbis

Amgen’s Lumykras gains MHRA approval under Project Orbis

Amgen’s first-in-class medicine Lumykras (sotorasib) has become the first new cancer therapy to receive Conditional Marketing Authorisation for use1 across England, Scotland and Wales...
Government plans revealed to reform adult social care and recover NHS

Government plans revealed to reform adult social care and recover NHS

The Prime Minister has set out plans to tackle the Covid backlogs, reform adult social care, and bring the health and social care system closer together...
NICE backs Janssen’s apalutamide for treatment of prostate cancer

NICE backs Janssen’s apalutamide for treatment of prostate cancer

The National Institute of Health and Care Excellence (NICE) has reconsidered its previous decision for Janssen’s Erleada®▼ (apalutamide) and published two positive Final Appraisal...
NHS England receives extra £5.4 billion to support COVID-19 response over next 6 months

NHS receives extra £5.4 billion to support COVID-19 response over next 6 months

The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that the NHS will receive an extra £5.4 billion over the...
NICE recommends Novartis’ secukinumab for children with moderate to severe psoriasis

NICE recommends Novartis’ secukinumab for children with moderate to severe psoriasis

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Cosentyx® (secukinumab) as an option for treating moderate to severe plaque psoriasis...
JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed

JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed

The Joint Committee on Vaccination and Immunisation (JCVI) is advising that people with severely weakened immune systems should have a third vaccine dose as...
NICE and Cochrane collaborate on ‘living’ recommendations for NHS and patients

NICE and Cochrane collaborate on ‘living’ recommendations for NHS and patients  

The National Institute for Health and Care Excellence (NICE) and Cochrane have signed a collaborative agreement which will help to deliver ‘living’ recommendations across...
World-first agreement between Novartis and NHS for cholesterol drug

World-first agreement between Novartis and NHS for cholesterol drug

Novartis has reached a commercial agreement with the NHS in England, enabling broad and rapid access to the cholesterol-lowering medicine Leqvio®▼(inclisiran). The collaboration pioneers...
New shingles vaccine available in UK

New GSK shingles vaccine available in UK

GlaxoSmithKline (GSK) has announced that Shingrix, a vaccine to help protect adults against shingles, is now available in the United Kingdom. The vaccine is licensed...
MHRA approval for Astellas’ roxadustat for anaemia of chronic kidney disease

MHRA approval for Astellas’ roxadustat for anaemia of chronic kidney disease

The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Astellas’ Evrenzo™▼ (roxadustat) for the treatment of adult patients with symptomatic anaemia associated with...

Latest articles

PM Society Digital Awards Winners 2021

PM Society Digital Awards Winners 2021

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology

New patient coalition launched for digital health technology

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
How to digitalise MSL teams for increased efficiency

How to digitalise MSL teams for increased efficiency

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
New patient coalition launched for digital health technology

New patient coalition launched for digital health technology

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
PM Society Digital Awards Winners 2021

PM Society Digital Awards Winners 2021

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the...
How to digitalise MSL teams for increased efficiency

How to digitalise MSL teams for increased efficiency

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription